Braveheart Bio

Braveheart Bio

Clinical Trial Manager

San Francisco, CA or Remote or Hybrid

Sponsorship not specified$140k-$170kDetected 29 days ago
ExcelClinical TrialsFDA RegulatoryLeadershipCommunicationCollaborationProblem SolvingTime ManagementPublic SpeakingAdaptabilityMicrosoft Office

About the role

  • The C linical Trial Manager (CTM) is a key member of the Clinical Operations team and will report into the Clinical Program Manager, Clinical Operations, partnering closely on the start-up and initiation of a global Phase 3 program.

Responsibilities

  • Maintain internal Clinical Operations databases and document repositories.
  • Perform administrative duties in a timely manner as assigned.
  • Guide and support junior team members, ensuring alignment on deliverables, timelines, and quality standards.
  • Experience as the regional lead for Europe strongly preferred

Requirements

  • valid travel documents must be obtainable.
  • Assist Clinical Program Manager, ClinOps with oversight of CRO and set-up of vendors as required, including liaising with Global CRO to ensure timely initiation of study.
  • Day-to-day contact with counterparts at CRO and/or trial sites, including daily review and identification of potential issues or problems that must be communicated/escalated directly to Clinical Program Manager, ClinOps.
  • Required experience &
  • Required experience & skills:

Skills

  • At least 4+ years of relevant experience with a BS or BA in a relevant scientific discipline or an RN (2- or 3-year certificate)
  • Excellent attention to detail, interpersonal and presentation skills are a critical asset
  • Excellent organizational, problem-solving and time management skills
  • Must be familiar with routine medical/scientific terminology
  • Knowledge of FDA and/or EMEA Regulations, ICH Guidelines, and GCPs governing the conduct of clinical trials is desirable
  • Must be familiar with Word, PowerPoint, and Excel (intermediate or higher excel proficiency a plus)
  • Must be able to participate in departmental or interdepartmental strategic initiatives under general supervision
  • High energy level, personal productivity, creativity and commitment
  • Highly adaptable team-player
  • Strong written and verbal communication skills with a collaborative, team-oriented approach
  • Ability to thrive in a fast-paced, dynamic environment and remain comfortable with change and ambiguity
  • Flexible, proactive, and hands-on mindset with a roll-up-your-sleeves, can-do attitude

Compensation

  • $140,000 - $170,000
  • This role is eligible for a competitive total rewards package, including an annual bonus, equity, and a comprehensive benefits offering.
  • Braveheart participates in the federal E ‑ Verify program to confirm employment authorization for all new hires.
  • To learn more about E-Verify please review this poster.

Benefits

  • Relevant clinical trial experience in the pharmaceutical or health care industry.

Company info

  • Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.
  • With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.
  • The role:
  • The C linical Trial Manager (CTM) is a key member of the Clinical Operations team and will report into the Clinical Program Manager, Clinical Operations, partnering closely on the start-up and initiation of a global Phase 3 program. The primary responsibilit ie s of the CTM will be regional study management of the EU and vendor management.
  • Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.
  • Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
  • Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.
  • The primary responsibilit ie s of the CTM will be regional study management of the EU and vendor management.

Equal opportunity

  • We are an equal opportunity employer.
Apply directly at Braveheart Bio →Create a free account for alerts like thisView Braveheart Bio immigration profile

This listing is sourced directly from Braveheart Bio's careers page and normalized into a canonical job model.